Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco van Doorn

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|January 19, 2021
Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort studyBabette J A Verkouteren, Marlies Wakkee, An K L Reyners, et al.
JAMA Dermatology|June 9, 2016
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis FungoidesSuzanne van Santen, Rachel E J Roach, Remco van Doorn, et al.
Cancer Research|April 17, 2008
Novel and highly recurrent chromosomal alterations in Sézary syndromeMaarten H Vermeer, Remco van Doorn, Remco Dijkman, et al.
Familial Cancer|October 5, 2015
Germline TERT promoter mutations are rare in familial melanomaMark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repairDiana van den Heuvel, Mihyun Kim, Annelotte P Wondergem, et al.
Ebiomedicine|March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumoursChiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Communications Biology|November 13, 2025
Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody bindingAnneloes van der Plas-van Duijn, Levi M T Winkelman, Claire Lensen, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Cancer Cell|July 12, 2011
Proinvasion metastasis drivers in early-stage melanoma are oncogenesKenneth L Scott, Cristina Nogueira, Timothy P Heffernan, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|January 19, 2021
Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort studyBabette J A Verkouteren, Marlies Wakkee, An K L Reyners, et al.
JAMA Dermatology|June 9, 2016
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis FungoidesSuzanne van Santen, Rachel E J Roach, Remco van Doorn, et al.
Cancer Research|April 17, 2008
Novel and highly recurrent chromosomal alterations in Sézary syndromeMaarten H Vermeer, Remco van Doorn, Remco Dijkman, et al.
Familial Cancer|October 5, 2015
Germline TERT promoter mutations are rare in familial melanomaMark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repairDiana van den Heuvel, Mihyun Kim, Annelotte P Wondergem, et al.
Ebiomedicine|March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumoursChiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Communications Biology|November 13, 2025
Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody bindingAnneloes van der Plas-van Duijn, Levi M T Winkelman, Claire Lensen, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Cancer Cell|July 12, 2011
Proinvasion metastasis drivers in early-stage melanoma are oncogenesKenneth L Scott, Cristina Nogueira, Timothy P Heffernan, et al.
Pageof 12